“The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis”, J of Skin, vol. 10, no. 2, p. s767, Mar. 2026, doi: 10.25251/q0ctfz86.